(Q27853195)

English

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry

scientific article

In more languages

Statements

scholarly article

1 reference

13 November 2016

Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: a retrospective analysis of a prospective clinical trial and validation in a population-based registry (English)

1 reference

13 November 2016

0 references

0 references

follicular lymphoma

1 reference

based on heuristic

inferred from title

Martin Dreyling

22

0 references

29

0 references

Andreas Rosenwald

28

0 references

Monika Szczepanowski

6

object named as

Monika Szczepanowski

0 references

object named as

Eva Hoster

4

0 references

Joseph M Connors

20

object named as

Joseph M Connors

0 references

Randy D Gascoyne

33

object named as

Randy D Gascoyne

0 references

Wolfgang Hiddemann

32

object named as

Wolfgang Hiddemann

0 references

Christiane Pott

7

object named as

Christiane Pott

0 references

23

object named as

Donna Neuberg

0 references

21

object named as

Laurie H Sehn

0 references

13

object named as

Anja Mottok

0 references

11

object named as

Ellen Leich

0 references

Vindi Jurinovic

2

object named as

Vindi Jurinovic

0 references

3

object named as

Robert Kridel

0 references

Annette M Staiger

5

object named as

Annette M Staiger

0 references

12

object named as

Alden A Moccia

0 references

Daisuke Ennishi

17

object named as

Daisuke Ennishi

0 references

Hennady P Shulha

18

object named as

Hennady P Shulha

0 references

Christoffer Hother

19

object named as

Christoffer Hother

0 references

Wolfram Klapper

30

object named as

Wolfram Klapper

0 references

35

object named as

Oliver Weigert

0 references

Michael Unterhalt

31

object named as

Michael Unterhalt

0 references

author name string

Alessandro Pastore

1

0 references

Nadja Kopp

8

0 references

Mark Murakami

9

0 references

Heike Horn

10

0 references

Ashwini Sunkavalli

14

0 references

Paul Van Hummelen

15

0 references

Matthew Ducar

16

0 references

Peter Möller

24

0 references

Alfred C Feller

25

0 references

Martin L Hansmann

26

0 references

Harald Stein

27

0 references

David M Weinstock

34

0 references

publication date

September 2015

0 references

Lancet Oncology Commission

0 references

16

0 references

1111-22

0 references

9

0 references

Epidemiology of the non-Hodgkin's lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin's Lymphoma Classification Project

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

How we manage follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): a phase 3, randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic factors in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular lymphoma international prognostic index.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The Follicular Lymphoma International Prognostic Index (FLIPI) separates high-risk from intermediate- or low-risk patients with advanced-stage follicular lymphoma treated front-line with rituximab and the combination of cyclophosphamide, doxorubicin

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Pathogenesis of follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP al

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

A targeted mutational landscape of angioimmunoblastic T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Discovery and saturation analysis of cancer genes across 21 tumour types

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutational heterogeneity in cancer and the search for new cancer-associated genes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Predicting the functional impact of protein mutations: application to cancer genomics

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical effect of point mutations in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The identification of discrete prognostic groups in low grade non-Hodgkin's lymphoma. The Scotland and Newcastle Lymphoma Group Therapy Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Dissecting follicular lymphoma: high versus low risk

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Correcting for noncompliance and dependent censoring in an AIDS Clinical Trial with inverse probability of censoring weighted (IPCW) log-rank tests.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Somatic mutations at EZH2 Y641 act dominantly through a mechanism of selectively altered PRC2 catalytic activity, to increase H3K27 trimethylation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27)

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Oncogenic CARD11 mutations in human diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The genomic landscape of Waldenstrom macroglobulinemia is characterized by highly recurring MYD88 and WHIM-like CXCR4 mutations, and small somatic deletions associated with B-cell lymphomagenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Analysis of FOXO1 mutations in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Activating STAT6 mutations in follicular lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

MEF2B mutations lead to deregulated expression of the oncogene BCL6 in diffuse large B cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Recurrent targets of aberrant somatic hypermutation in lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

EZH2 mutations are frequent and represent an early event in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

The presence of TP53 mutation at diagnosis of follicular lymphoma identifies a high-risk group of patients with shortened time to disease progression and poorer overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Acquired TNFRSF14 mutations in follicular lymphoma are associated with worse prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

High rate of TNFRSF14 gene alterations related to 1p36 region in de novo follicular lymphoma and impact on prognosis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

EZH2 is required for germinal center formation and somatic EZH2 mutations promote lymphoid transformation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2815%2900169-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(15)00169-2

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q27853195&oldid=2092777204"